These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 336499)

  • 21. Lymphocyte sensitization detected in lymphomatous hamadryas baboons by the macrophage electrophoretic mobility assay.
    Malkovský M; Bubeník J; Indzhiya LV; Lapin BA; Yakovleva LA
    Folia Biol (Praha); 1980; 26(1):70-3. PubMed ID: 6244991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitization of normal mouse lymphocytes immunized in vitro as detected by macrophage electrophoretic mobility (MEM) test.
    Nĕmecková S; Bubeník J; Indrová M
    Folia Biol (Praha); 1982; 28(4):280-2. PubMed ID: 7141039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Technical aspects of the macrophage electrophoretic mobility test in transplantation immunity.
    Malkovský M; Bubeník J; Holán V; Hasek M
    Folia Biol (Praha); 1979; 25(3):179-87. PubMed ID: 385372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunologic localization of primary tumors].
    Muhrer KH; Filler D; Pasurka B
    Chirurg; 1982 Apr; 53(4):258-62. PubMed ID: 7083967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The macrophage electrophoretic migration (MEM) test for lymphocyte sensitization. A study of the kinetics.
    Carnegie PR; Caspary EA; Dickinson JP; Field EJ
    Clin Exp Immunol; 1973 May; 14(1):37-45. PubMed ID: 4716103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunology of auto-immune disorders].
    Berthaux P
    Bull Soc Sci Med Grand Duche Luxemb; 1973 Nov; 110(2):165-73. PubMed ID: 4543895
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunological activity of blood lymphocyte fractions. A study by the macrophage electrophoretic mobility method.
    Minderhoud JM; Smith JK
    Clin Exp Immunol; 1972 Apr; 10(4):571-9. PubMed ID: 5034245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspects of cellular immunity in multiple sclerosis. Antigen-reactivity of lymphocytes and lymphokine activity.
    Meyer-Rienecker HJ; Jenssen HL; Werner H
    J Neurol Sci; 1979 Jul; 42(2):173-86. PubMed ID: 90125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
    James SL; Lazdins JK; Hieny S; Natovitz P
    J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mediators in cellular immunity (author's transl)].
    Sawada J; Osawa T
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):860-75. PubMed ID: 4612616
    [No Abstract]   [Full Text] [Related]  

  • 33. Immune surveillance in multiple sclerosis patients treated with natalizumab.
    Stüve O; Marra CM; Jerome KR; Cook L; Cravens PD; Cepok S; Frohman EM; Phillips JT; Arendt G; Hemmer B; Monson NL; Racke MK
    Ann Neurol; 2006 May; 59(5):743-7. PubMed ID: 16634029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunology of multiple sclerosis. Recent data and therapeutic perspectives].
    Tourbah A; Fontaine B; Lyon-Caen O
    Rev Neurol (Paris); 1993; 149(6-7):373-84. PubMed ID: 8303156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Aspects of immunologic diagnosis of brain tumors. Results with tumor-associated membrane antigens and the electrophoretic mobility test (author's transl)].
    Meyer-Rienecker H; Jenssen HL; Werner H
    Arch Psychiatr Nervenkr (1970); 1979; 227(2):121-33. PubMed ID: 543792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lymphocyte reactivity against fetal antigens during the growth and regression of experimental tumors].
    Schlott B; Gryschek G; Albrecht S; Pasternak G
    Biomed Biochim Acta; 1985; 44(5):805-11. PubMed ID: 4062925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of teem-test for investigations of cellular immune phenomena in multiple sclerosis.
    Jenssen HL; Meyer-Rienecker HJ; Werner H; Köhler H; Wegener S
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):565-72. PubMed ID: 147094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of the macrophage electrophoretic mobility test for the diagnosis of eye diseases.
    Jenssen R; Jenssen HL; Köhler H; Friemel H
    Mod Probl Ophthalmol; 1976; 16():259-64. PubMed ID: 943037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunological laboratory studies in neurological diagnosis].
    Silvennoinen-Kassinen S
    Duodecim; 1986; 102(5):300-5. PubMed ID: 3516641
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunodiagnostic of multiple sclerosis by estimation of lymphokines in vitro and in vivo.
    Meyer-Reinecker HJ; Jenssen HL; Werner H; Hitzschke B
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):573-82. PubMed ID: 305250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.